International Biotechnology (LON:IBT) Shares Pass Above Two Hundred Day Moving Average – Should You Sell?

International Biotechnology (LON:IBT)’s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 803.83 and traded as high as GBX 990. International Biotechnology shares last traded at GBX 982, with a volume of 32,813 shares trading hands.

International Biotechnology Stock Up 0.4%

The stock has a market cap of £314.64 million, a price-to-earnings ratio of -299.77 and a beta of 0.21. The company has a 50 day simple moving average of GBX 955.14 and a 200 day simple moving average of GBX 803.83.

International Biotechnology (LON:IBT) last posted its quarterly earnings results on Thursday, November 6th. The company reported GBX (11.42) earnings per share for the quarter. International Biotechnology had a net margin of 90.66% and a return on equity of 13.67%. As a group, analysts predict that International Biotechnology will post 0.9435943 earnings per share for the current fiscal year.

International Biotechnology Company Profile

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.